These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33378783)

  • 1. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness.
    Lippi G; Henry BM; Sanchis-Gomar F
    Semin Thromb Hemost; 2021 Jun; 47(4):460-462. PubMed ID: 33378783
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.
    Kazmi S; Herekar F; Sarfaraz S
    Semin Thromb Hemost; 2021 Jun; 47(4):427-430. PubMed ID: 33336328
    [No Abstract]   [Full Text] [Related]  

  • 3. Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?
    Harenberg J; Bauersachs R; Ageno W
    Semin Thromb Hemost; 2021 Jun; 47(4):338-340. PubMed ID: 32882715
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic Value of Antithrombin Levels in COVID-19 Patients and Impact of Fresh Frozen Plasma Treatment: A Retrospective Study.
    Anaklı İ; Ergin Özcan P; Polat Ö; Orhun G; Alay GH; Tuna V; Çeliksoy E; Kılıç M; Mercan M; Ali A; Beşışık S; Esen F
    Turk J Haematol; 2021 Feb; 38(1):15-21. PubMed ID: 33486940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.
    Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2021 Jun; 47(4):333-337. PubMed ID: 34062596
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean Platelet Volume Predicts Severe COVID-19 Illness.
    Lippi G; Henry BM; Favaloro EJ
    Semin Thromb Hemost; 2021 Jun; 47(4):456-459. PubMed ID: 33893630
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19-related laboratory coagulation findings.
    Devreese KMJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.
    Takahashi W; Yoneda T; Koba H; Ueda T; Tsuji N; Ogawa H; Asakura H
    Int J Infect Dis; 2021 Jan; 102():529-531. PubMed ID: 33157292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
    White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
    Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness.
    Mir N; D'Amico A; Dasher J; Tolwani A; Valentine V
    Blood Rev; 2021 Jan; 45():100731. PubMed ID: 32829961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
    Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
    Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage.
    Stillson JE; Bunch CM; Gillespie L; Khan R; Wierman M; Pulvirenti J; Phyu H; Anderson S; Al-Fadhl M; Thomas AV; Kwaan HC; Moore E; Moore H; Walsh MM
    Semin Thromb Hemost; 2021 Jun; 47(4):442-446. PubMed ID: 33607668
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
    Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
    Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 versus HIT hypercoagulability.
    Warkentin TE; Kaatz S
    Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of coagulation disturbances with severity of COVID-19: a longitudinal study.
    Lu H; Chen M; Tang S; Yu W
    Hematology; 2021 Dec; 26(1):656-662. PubMed ID: 34493174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
    Horowitz NA; Brenner B
    Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.